Alle Storys
Folgen
Keine Story von Deutsche Effecten- und Wechsel-Beteiligungsges. AG mehr verpassen.

Deutsche Effecten- und Wechsel-Beteiligungsges. AG

DEWB continues to expand investment business in first half of 2008

Jena, 7 August 2008 (euro adhoc) -

- Investment activity expanded
- Further successful development of portfolio companies 
- Repayment of bank liabilities concluded
  ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
  the content of this announcement.
balance
Deutsche Effecten- und
Wechsel-Beteiligungsgesellschaft AG, (DEWB), Jena, today published 
its financial results for the first half of 2008. In the first six 
months of the current fiscal year the focus of activities was on new 
investments and the systematic development of the portfolio 
companies; as planned, there was no sale of holdings. Accordingly 
earnings from operating activities (EBIT), at -0,7 million Euros, 
came in at the same level as in the first half 2007. The result after
taxes improved slightly, to -0.7 million Euros (H1t half 2007: -0.8 
million Euros). Primarily due to the repayment of the bank 
liabilities of 5.0 million Euros, the balance sheet total as at 30 
June 2008 reduced to 66.1 million Euros. Thus since 2005 DEWB has 
reduced debts by 50.9 million Euros. Cash decreased to 10 million 
Euros, due to both the reduction of the loan and to investments in 
the portfolio, compared to 31 December 2007. Shareholders´ equity 
fell slightly to 45.4 million Euros due to the result for the period.
The Net Asset Value (NAV) per share was 2.98 Euro (31 December 2007: 
3.03 Euro/share), at a current DEWB share price of 2.35 Euro (6 
August 2008).
Investments expanded markedly In April DEWB took a stake in two 
promising companies within its investment focus on photonics and 
sensor systems: Nanda Technologies GmbH, Unterschleissheim, develops 
and produces optical inspection equipment for process controls in the
semiconductor manufacturing area. Based on a new optical design 
combined with innovative image processing, Nandas product has the 
potential to revolutionize quality control in the field of 
semiconductor manufacture. Nanotron Technologies GmbH, Berlin, is a 
leader in the development and the sale of wireless sensor networks as
well as solutions for radio-based communication and object 
localisation. With its own patented transmission systems, 
substantially superior to that of competing products, Nanotron shows 
above-average growth potential.
As at 30 June 2008 DEWB holds 12 investments. The valuation of the 
portfolio in the balance sheet amounts to 48.4 million Euros and has 
increased substantially compared with 31 December 2007 (40.6 million 
Euros). In the first half of 2008, DEWB invested 7.9 million Euros in
total. The share taken by photonics and sensor systems thereby rose 
to 58 percent.
KSW Microtec successfully implements strategy The portfolio companies
of DEWB have developed well, despite signs of gloom in the economy 
overall, posting growth in incoming orders. KSW Microtec AG has 
pressed ahead consistently with the extension of its product 
portfolio, thus effecting market entry into business sectors with 
strong margins. KSW, ranking amongst the leading manufacturers of 
RFID components worldwide, thereby seeks to gain further market 
shares, with increasing profitability. "KSW´s strategy is bearing its
first fruits. Other companies in the market are also increasingly 
convinced by the company´s positioning. Thus the recently-announced 
commitment to DEWB made by RFID investor Bluehill demonstrates the 
increased level of interest in KSW from investors and competitors", 
Bertram Köhler, Member of the Management Board of DEWB, remarked on 
the development at KSW.
NOXXON Pharma gains a further cooperation partner The portfilio 
company NOXXON Pharma AG, developer of active agents based on 
proprietary spiegelmer technology, concluded a cooperation agreement 
with the US pharmaceutical giant Eli Lilly in the first half of the 
current fiscal year. Within this contract NOXXON is granting Eli 
Lilly an exclusive worldwide licence for a pre-clinical spiegelmer 
against migraine and and will use its Spiegelmer technology to 
identify follow-on inhibitors. Eli Lilly is taking over the 
pre-clinical and clinical development of the molecules identified, as
well as the worldwide commercialisation of the products emerging from
this work. In addition to receiving an advance payment and further 
milestone-dependent remunerations, NOXXON is eligible to earn 
royalties on worldwide sales of products commercialized by Lilly as a
result of this collaboration. Eli Lilly is the fourth large 
international pharmaceutical company, in addition to Pfizer, Dow 
Chemical and Roche, to recognize the potential of NOXXON and position
itself accordingly within the scope of cooperation agreements.
end of announcement                               euro adhoc

Further inquiry note:

DEWB AG
Marco Scheidler
Leutragraben 1
Germany, 07743 Jena
Tel: +49 (0) 3641 573 3600
Fax: +49 (0) 3641 573 3610
E-Mail: ir@dewb-vc.com
www.dewb-vc.com

Branche: Financial & Business Services
ISIN: DE0008041005
WKN: 804100
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse München / free trade

Weitere Storys: Deutsche Effecten- und Wechsel-Beteiligungsges. AG
Weitere Storys: Deutsche Effecten- und Wechsel-Beteiligungsges. AG
  • 08.05.2008 – 10:48

    Nanda Technologies raises 8m USD in a financing round led by DEWB and BrainsToVentures

    - Innovative wafer inspection system for the semiconductor industry - Largest Series B financing round to date of any company in the portfolio of the High-Tech Gruenderfonds ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. merger, acquisition and takeover/new investment Jena/St. ...

  • 14.04.2008 – 08:24

    DEWB and zouk ventures acquire a majority stake in Nanotron

    - Unique radio communication and tracking system with a broad range of applications in the strong growth RTLS market - 11 million Euro financing round for further expansion ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. merger, acquisition and takeover Jena/London/Berlin, 14 April 2008 (euro adhoc) - Deutsche Effecten- und ...

  • 28.02.2008 – 08:11

    DEWB increases Net Asset Value in 2007 markedly and sets the course for further growth

    - Net Asset Value per share increased to 3.03 Euros - Assets under Management raised to over 70 million Euros - Photonics and sensor systems share of the portfolio exceeds 50 percent - Appointment of the members of the Management Board extended ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this ...